Shaping the Future of Digitally Enabled Health and Care.

digital solutions medicines management patient safety remote monitoring

Journal

Pharmacy (Basel, Switzerland)
ISSN: 2226-4787
Titre abrégé: Pharmacy (Basel)
Pays: Switzerland
ID NLM: 101678532

Informations de publication

Date de publication:
12 Jan 2021
Historique:
received: 22 12 2020
revised: 07 01 2021
accepted: 09 01 2021
entrez: 15 1 2021
pubmed: 16 1 2021
medline: 16 1 2021
Statut: epublish

Résumé

People generally need more support as they grow older to maintain healthy and active lifestyles. Older people living with chronic conditions are particularly dependent on healthcare services. Yet, in an increasingly digital society, there is a danger that efforts to drive innovations in eHealth will neglect the needs of those who depend on healthcare the most-our ageing population. The SHAPES (Smart and Healthy Ageing through People Engaging in Supportive Systems) Innovation Action aims to create an open European digital platform that facilitates the provision of meaningful, holistic support to older people living independently. A pan-European pilot campaign will evaluate a catalogue of digital solutions hosted on the platform that have been specifically adapted for older people. 'Medicines control and optimisation' is one of seven themes being explored in the campaign and will investigate the impact of digital solutions that aim to optimise medicines use by way of fostering effective self-management, while facilitating timely intervention by clinicians based on remote monitoring and individualised risk assessments powered by artificial intelligence. If successful, the SHAPES Innovation Action will lead to a greater sense of self-sufficiency and empowerment in people living with chronic conditions as they grow older.

Identifiants

pubmed: 33445509
pii: pharmacy9010017
doi: 10.3390/pharmacy9010017
pmc: PMC7838996
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Horizon 2020 Framework Programme
ID : 857159

Références

Int J Clin Pharm. 2017 Apr;39(2):343-353
pubmed: 28238102

Auteurs

Maureen Spargo (M)

Medicines Optimisation Innovation Centre, Northern Health and Social Care Trust, Antrim BT41 2RL, UK.

Nicola Goodfellow (N)

Medicines Optimisation Innovation Centre, Northern Health and Social Care Trust, Antrim BT41 2RL, UK.

Claire Scullin (C)

Medicines Optimisation Innovation Centre, Northern Health and Social Care Trust, Antrim BT41 2RL, UK.

Sonja Grigoleit (S)

Fraunhofer Institute for Technological Trend Analysis INT, 53879 Euskirchen, Germany.

Andreas Andreou (A)

Department of Computer Science Mobile Systems Laboratory (MoSys Lab), University of Nicosia Research Foundation, Nicosia 1700, Cyprus.

Constandinos X Mavromoustakis (CX)

Department of Computer Science Mobile Systems Laboratory (MoSys Lab), University of Nicosia Research Foundation, Nicosia 1700, Cyprus.

Bárbara Guerra (B)

EDGENEERING, Lda, 1600-001 Lisbon, Portugal.

Marco Manso (M)

EDGENEERING, Lda, 1600-001 Lisbon, Portugal.

Nekane Larburu (N)

Vicomtech Research Centre, 20009 Donostia-San-Sebastian, Spain.

Óscar Villacañas (Ó)

Clínica Humana, 07010 Palma de Mallorca, Spain.

Glenda Fleming (G)

Medicines Optimisation Innovation Centre, Northern Health and Social Care Trust, Antrim BT41 2RL, UK.

Michael Scott (M)

Medicines Optimisation Innovation Centre, Northern Health and Social Care Trust, Antrim BT41 2RL, UK.

Classifications MeSH